Abstracts & posters

Abstract submission is closed

BMUC 2020 "light"

Check out the updated programme and register now for this meeting!

More info >

Abstracts & posters

Abstract submission is closed. All abstracts have been reviewed by the BMUC board and posters can be consulted here below.

Winning abstracts

Congratulations to the 3 winners of the poster contest!

These winners will receive a price of 1.500 euro – 1.000 euro and 750 euro, kindly offered by



Kim Van der Eecken Ghent University Hospital, Ghent, Belgium Tracking the origins of metastatic seeding in de novo metastatic prostate cancer
Romain Diamand Erasme Hospital, Brussels, Belgium External Validation of the Briganti Nomogram Predicting Lymph Node Invasion in Patients with Intermediate and High-risk Prostate Cancer Diagnosed with Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study
Wout Devlies University Hospitals Leuven, Leuven, Belgium Longitudinal analysis of urinary- and erectile function after RALP in high- versus low/intermediate-risk prostate cancer in a large prospective database

The top 3 abstract submitters have received a separate email regarding the oral presentation during the main scientific programme of BMUC 2020, currently cancelled due to the outbreak of COVID-19. More information will follow as soon as possible. A 4th winner can be selected by the audience onsite, in case the BMUC meeting will take place later this year.

Research grant

Congratulations to the research grant winner!

This winner will receive a price of 10.000 euro, kindly offer by




Anita Thomas University Hospitals Leuven Establishment of a cell-derived penile cancer xenograft in a humanized mouse


You can consult the posters of the submitted abstracts for BMUC 2020 here below. 

6. Unravelling the proteomic landscape of urinary extracellular vesicles in prostate cancer

Bert Dhondt, Ghent University Hospital, Ghent, Belgium

8. Impact of modern imaging tools on management of prostate cancer, a single center evaluation

Guillaume Grisay, Jolimont Hospital, Haine Saint-Paul, Belgium

13. Inferring the genomic landscape of lymph-node positive high-risk prostate cancer

Jan Vanwelkenhuyzen, University Ghent, Ghent, Belgium